Skip to content

Efficacy of minimally invasive surgical technique in the treatment of human intrabony defects with or without regenerative materials: a randomized-controlled trial

Efficacy of minimally invasive surgical technique in the treatment of human intrabony defects with or without regenerative materials: a randomized-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003939
Enrollment
Unknown
Registered
2013-12-01
Start date
2012-11-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal intrabony defect

Interventions

two-flap test group:Bio-Oss+Bio-Gide
single-flap test group:Bio-Oss

Sponsors

Peking University School of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with advanced periodontal disease, in general good health, presenting with at least one isolated deep, interdental intrabony defect, after completion of initial therapy and between 18 and 65 years old are considered eligible for this study; 2. Patients give informed written informed consent and are with optimal compliance; 3. Defect anatomy. Defects are located in incisors, premolars and the first molars. Presence of one tooth with probing depth (PD) and clinical attachment loss (CAL) >/=5mm associated with interdental intrabony defect depth of >/=3mm. Keratinized gingivae is enough to cover defects and grafts. Distance between bottom of the defect and apex is no less than 3mm; 4. Patients with good oral hygiene, presenting with full-mouth plaque scores (FMPS) </=20% and full-mouth bleeding scores (FMBS) </=25%.

Exclusion criteria

Exclusion criteria: 1. Poor oral hygiene; 2. Pregnant or lactating mothers; 3. Patients have oral cancer or HIV infection; 4. Tooth accepted regenerative therapy; 5. Teeth treated by regenerative therapy, with mobility greater than grade II and furcation involvement (class II and class III), with clinical signs of untreated acute infection at surgical site, apical pathology, root fracture and severe root irregularities are excluded; 6. Smokers (>10 cigarettes per day); 7. Patients who treated for other reasons in one month; 8. Patients have leukoplakia and erythema; 9. Patients allergy to the regenerative materials.

Design outcomes

Primary

MeasureTime frame
clinical attachment level (CAL);liner bone growt;

Secondary

MeasureTime frame
wound healing index;clinical probe depth;gingival recession;Bone probe level;volume of intrabony defect accessed by CBCT;Bone filling percentage;post-operative pain(VAS);

Countries

China

Contacts

Public ContactOuyang Xiangying

Peking University School of Stomatology

kqouyangy@bjmu.edu.cn+86 13621050102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026